Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 278

1.

The coxibs, selective inhibitors of cyclooxygenase-2.

FitzGerald GA, Patrono C.

N Engl J Med. 2001 Aug 9;345(6):433-42. Review. No abstract available.

PMID:
11496855
2.

The coxibs, selective inhibitors of cyclooxygenase-2.

Killen JP.

N Engl J Med. 2001 Dec 6;345(23):1708; author reply 1709. No abstract available.

PMID:
11759656
3.

[New anti-inflammatory analgetics--are they needed?].

Paakkari I.

Duodecim. 1999;115(20):2217-24. Review. Finnish. No abstract available.

PMID:
11973925
4.

[New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results].

Oliw E, Wollheim FA.

Lakartidningen. 2000 Jun 14;97(24):2942-4. Review. Swedish. No abstract available.

PMID:
10900877
5.

[Gastric protective pain therapy. What is the advantage of new COX-2 inhibitors?].

Hinz B, Brune K.

MMW Fortschr Med. 2000 Mar 16;142(11):39-40. German. No abstract available.

PMID:
10786088
6.

The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex).

Wynn RL.

Gen Dent. 2000 Jan-Feb;48(1):16-20. No abstract available.

PMID:
11199547
7.

Coxibs and cardiovascular disease.

Fitzgerald GA.

N Engl J Med. 2004 Oct 21;351(17):1709-11. Epub 2004 Oct 6. No abstract available.

8.

COX-2 inhibitors: new drugs for the management of pain and inflammation.

Hutchins V, Hutchins B.

Dent Today. 2001 Feb;20(2):56-61. No abstract available.

PMID:
12524847
9.

Summaries for patients. The cost-effectiveness of cyclooxygenase-2 inhibitors for treating chronic arthritis.

[No authors listed]

Ann Intern Med. 2003 May 20;138(10):I39. No abstract available.

PMID:
12755582
10.

[Coxibs, which real therapeutic advance?: Recent pharmacoepidemiological data].

Montastruc JL, Lapeyre-Mestre M, Gony M, Lugardon S, Bagheri H.

Therapie. 2004 Mar-Apr;59(2):201-5. Review. French.

PMID:
15366126
11.

COX-2 inhibitors--a lesson in unexpected problems.

Drazen JM.

N Engl J Med. 2005 Mar 17;352(11):1131-2. Epub 2005 Feb 15. No abstract available.

PMID:
15713947
12.

An update on specific COX-2 inhibitors: the COXIBs.

Gupta S, Crofford LJ.

Bull Rheum Dis. 2001;50(1):1-4. Review. No abstract available.

PMID:
12092091
13.

[Specific inhibitors of cyclooxygenase type 2] ].

Tomasová-Studýnková J.

Vnitr Lek. 2002 May;48(5):403-8. Review. Czech.

PMID:
12061207
14.

[Therapeutic advances with coxibs: few certainties and a lot of doubts].

Jouzeau JY, Daouphars M, Netter P.

Therapie. 2004 Mar-Apr;59(2):207-11. Review. French. No abstract available.

PMID:
15359614
15.

The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis.

Spiegel BM, Targownik L, Dulai GS, Gralnek IM.

Ann Intern Med. 2003 May 20;138(10):795-806. Review.

PMID:
12755551
16.

[COX-2 specific inhibitors: are NSAIDs and the stomach become reconcilied?].

Bannwarth B.

Gastroenterol Clin Biol. 2001 Apr;25(4 Suppl):B79-84. Review. French. No abstract available.

17.

COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.

Atkinson HG.

Health News. 2002 Aug;8(8):5. No abstract available.

PMID:
12206146
18.

COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.

Ray WA, MacDonald TM, Solomon DH, Graham DJ, Avorn J.

Pharmacoepidemiol Drug Saf. 2003 Jan-Feb;12(1):67-70. Review. No abstract available.

PMID:
12616850
19.

Efficacy of cyclooxygenase-2-specific inhibitors.

Cannon GW, Breedveld FC.

Am J Med. 2001 Feb 19;110 Suppl 3A:6S-12S. Review.

PMID:
11173044
20.

[Clinical use of COX-2 inhibitors].

Ristić GG, Stefanović DZ.

Vojnosanit Pregl. 2001 May-Jun;58(3):283-95. Review. Serbian. No abstract available.

PMID:
11548555

Supplemental Content

Support Center